Over the last decade, with increasing use of aggressive chemotherapy and bone marrow transplantation in the treatment of cancer, fungi have emerged as a major pathogen. The prognosis of established systemic fungal infections remains poor, but newer antifungal drugs such as fluconazole are changing the outlook of therapy and prophylaxis considerably.
|Original language||English (US)|
|Number of pages||5|
|Journal||Indian journal of cancer|
|State||Published - Sep 1994|
ASJC Scopus subject areas